Danaher Total Liabilities 2011-2025 | DHR
Danaher total liabilities from 2011 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Danaher total liabilities for the quarter ending September 30, 2025 were $28.817B, a 1.68% decline year-over-year.
- Danaher total liabilities for 2024 were $27.992B, a 9.7% decline from 2023.
- Danaher total liabilities for 2023 were $30.998B, a 9.52% decline from 2022.
- Danaher total liabilities for 2022 were $34.26B, a 9.86% decline from 2021.
|
Danaher Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $27,992 |
| 2023 | $30,998 |
| 2022 | $34,260 |
| 2021 | $38,007 |
| 2020 | $36,384 |
| 2019 | $31,800 |
| 2018 | $19,606 |
| 2017 | $20,281 |
| 2016 | $22,219 |
| 2015 | $24,458 |
| 2014 | $13,542 |
| 2013 | $12,221 |
| 2012 | $13,857 |
| 2011 | $12,978 |
| 2010 | $8,444 |
|
Danaher Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-09-30 | $28,817 |
| 2025-06-30 | $29,278 |
| 2025-03-31 | $28,259 |
| 2024-12-31 | $27,992 |
| 2024-09-30 | $29,310 |
| 2024-06-30 | $28,653 |
| 2024-03-31 | $29,955 |
| 2023-12-31 | $30,998 |
| 2023-09-30 | $35,319 |
| 2023-06-30 | $33,178 |
| 2023-03-31 | $33,554 |
| 2022-12-31 | $34,260 |
| 2022-09-30 | $34,037 |
| 2022-06-30 | $35,205 |
| 2022-03-31 | $37,030 |
| 2021-12-31 | $38,007 |
| 2021-09-30 | $39,037 |
| 2021-06-30 | $35,261 |
| 2021-03-31 | $34,996 |
| 2020-12-31 | $36,384 |
| 2020-09-30 | $34,918 |
| 2020-06-30 | $34,996 |
| 2020-03-31 | $37,864 |
| 2019-12-31 | $31,800 |
| 2019-09-30 | $28,336 |
| 2019-06-30 | $21,109 |
| 2019-03-31 | $20,206 |
| 2018-12-31 | $19,606 |
| 2018-09-30 | $20,034 |
| 2018-06-30 | $20,831 |
| 2018-03-31 | $19,943 |
| 2017-12-31 | $20,281 |
| 2017-09-30 | $20,471 |
| 2017-06-30 | $21,052 |
| 2017-03-31 | $21,454 |
| 2016-12-31 | $22,219 |
| 2016-09-30 | $18,033 |
| 2016-06-30 | $26,383 |
| 2016-03-31 | $23,809 |
| 2015-12-31 | $24,458 |
| 2015-09-30 | $26,524 |
| 2015-06-30 | $12,815 |
| 2015-03-31 | $12,682 |
| 2014-12-31 | $13,542 |
| 2014-09-30 | $11,726 |
| 2014-06-30 | $11,863 |
| 2014-03-31 | $12,014 |
| 2013-12-31 | $12,221 |
| 2013-09-30 | $12,350 |
| 2013-06-30 | $12,744 |
| 2013-03-31 | $12,720 |
| 2012-12-31 | $13,857 |
| 2012-09-30 | $12,633 |
| 2012-06-30 | $12,803 |
| 2012-03-31 | $12,530 |
| 2011-12-31 | $12,978 |
| 2011-09-30 | $14,056 |
| 2011-06-30 | $14,958 |
| 2011-03-31 | $8,311 |
| 2010-12-31 | $8,444 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $156.252B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCA Healthcare (HCA) | United States | $107.856B | 17.86 |
| CVS Health (CVS) | United States | $98.775B | 11.36 |
| Elevance Health (ELV) | United States | $72.412B | 10.62 |
| Cencora (COR) | United States | $70.172B | 22.64 |
| Natera (NTRA) | United States | $28.194B | 0.00 |
| DiDi Global (DIDIY) | China | $24.803B | 20.27 |
| Labcorp Holdings (LH) | United States | $22.125B | 16.87 |
| Medpace Holdings (MEDP) | United States | $16.622B | 41.26 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.514B | 0.00 |
| Solventum (SOLV) | United States | $13.123B | 12.74 |
| ICON (ICLR) | Ireland | $13.097B | 12.99 |
| Viatris (VTRS) | United States | $12.347B | 4.60 |
| CochLear (CHEOY) | Australia | $11.709B | 0.00 |
| Revvity (RVTY) | United States | $10.513B | 19.36 |
| HealthEquity (HQY) | United States | $8.768B | 35.09 |
| Charles River Laboratories (CRL) | United States | $8.259B | 15.91 |
| Sonic Healthcare (SKHHY) | Australia | $6.885B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.729B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.771B | 34.41 |
| Bausch + Lomb (BLCO) | Canada | $5.525B | 36.28 |
| Sotera Health (SHC) | United States | $4.443B | 21.42 |
| GeneDx Holdings (WGS) | United States | $3.702B | 65.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.560B | 20.77 |
| Alignment Healthcare (ALHC) | United States | $3.306B | 0.00 |
| Concentras Parent (CON) | United States | $2.489B | 15.54 |
| Premier (PINC) | United States | $2.327B | 22.55 |
| Progyny (PGNY) | United States | $2.117B | 41.61 |
| Pediatrix Medical (MD) | United States | $1.988B | 11.87 |
| Surgery Partners (SGRY) | United States | $1.976B | 25.47 |
| Organon (OGN) | United States | $1.958B | 2.06 |
| Establishment Labs Holdings (ESTA) | $1.859B | 0.00 | |
| PACS (PACS) | United States | $1.612B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.228B | 0.00 |
| Omada Health (OMDA) | $1.161B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.008B | 16.50 |
| Embecta (EMBC) | United States | $0.851B | 4.98 |
| CareDx (CDNA) | United States | $0.820B | 13.39 |
| InnovAge Holding (INNV) | United States | $0.657B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.610B | 8.41 |
| Sonida Senior Living (SNDA) | United States | $0.606B | 0.00 |
| Nutex Health (NUTX) | United States | $0.595B | 9.01 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.500B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.434B | 0.00 |
| Enhabit (EHAB) | United States | $0.409B | 18.39 |
| Strata Critical Medical (SRTA) | United States | $0.391B | 0.00 |
| Pomdoctor - (POM) | China | $0.386B | 0.00 |
| Oncology Institute (TOI) | United States | $0.371B | 0.00 |
| So-Young (SY) | China | $0.369B | 0.00 |
| SBC Medicals (SBC) | United States | $0.344B | 6.25 |
| Shoulder Innovations (SI) | United States | $0.303B | 0.00 |
| KindlyMD (NAKA) | United States | $0.270B | 0.00 |
| Agilon Health (AGL) | United States | $0.239B | 0.00 |
| LifeMD (LFMD) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.163B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 33.37 |
| Ascend Wellness Holdings (AAWH) | United States | $0.112B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| DocGo (DCGO) | United States | $0.105B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.024B | 7.21 |
| Basel Medical Group (BMGL) | Singapore | $0.022B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |